T1	Participants 157 162	China
T2	Participants 459 522	Patients who had complete symptom relief in the initial therapy
T3	Participants 1006 1206	398 patients were recruited in the initial therapy group, among whom 253 were included in on-demand therapy, with 127 patients in the hydrotalcite group and the remaining 126 in the esomeprazole group
